Reversible cognitive and neurological symptoms during valproic acid therapy [6]

Journal of the American Geriatrics Society

Volumn 55, Issue 4, 2007, Pages 628-

  Hommet, Caroline ^a   Mondon, Karl ^a   De Toffol, Bertrand ^a   Constans, Thierry ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; VALPROIC ACID;

AGED; ANOREXIA; ATAXIA; BRADYPSYCHIA; CASE REPORT; CEREBELLUM DISEASE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DAILY LIFE ACTIVITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; LEUKOARAIOSIS; MALE; MEMORY; MOOD DISORDER; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOMOTOR DISORDER; RECURRENT DISEASE; SIDE EFFECT; SOMNOLENCE; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; TREMOR; VERTIGO;

AGED, 80 AND OVER; ANTICONVULSANTS; ATAXIA; COGNITION DISORDERS; HUMANS; MALE; SEIZURES; VALPROIC ACID;

EID: 33947718824     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01117.x     Document Type: Letter

References (7)

1. Read CL, Stephen LJ, Stolarek IW et al. Cognitive effects of anticonvulsivant monotherapy in elderly patients: A placebo-controlled study. Seizure 1998; 7:159-162.
2. Bergey GK. Initial treatment of epilepsy. Special issues in treating the elderly. Neurology 2004;63:S40-S48.
3. Kwan P, Brodie MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001;357:216-222.
4. Stephen LJ. Drug treatment of epilepsy in elderly people. Focus on valproic acid. Drugs Aging 2003;20/2:141-152.
5. Armon C, Shin C, Miller P et al. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996;47:626-635.
6. Masmoudi K, Gras-Champel V, Masson H et al. Parkinsonism and/or cognitive impairment with valproic acid therapy: A report of ten cases. Pharmacopsychiatry 2006;39:9-12.
7. Papazian O, Carnizales E, Alfonso I et al. Reversible dementia and apparent brain atrophy during valproate therapy. Ann Neurol 1995;38:687-691.